GSAP

GSAP

Target · Gamma-secretase regulator

GSAP Gamma-secretase activating protein · pigeon homolog

GSAP (gamma-secretase activating protein, also known as PION) is a regulator of gamma-secretase that selectively promotes the production of amyloid-beta. It acts without affecting the processing of other gamma-secretase substrates such as Notch. Browse Assay Genie's current range of GSAP research reagents below, or read on for the biology behind the target.

trans-Golgi network proteinGamma-secretase regulatorSelectively raises amyloid-beta
854 aa
Protein length
~98 kDa
Molecular weight
7q11.23
Gene locus
GSAP family
Protein family
Target information

What is GSAP (gamma-secretase activating protein)?

GSAP is a regulator of gamma-secretase activity. The gamma-secretase complex is an endoprotease complex that catalyses the intramembrane cleavage of integral membrane proteins, including Notch receptors and the amyloid-beta precursor protein (APP). GSAP specifically activates the production of amyloid-beta 40 and amyloid-beta 42, without affecting cleavage of other gamma-secretase targets such as Notch.

Mechanistically, GSAP promotes the gamma-cleavage of the APP C-terminal fragment (APP-CTF, also called CTF-alpha) by gamma-secretase to generate amyloid-beta. At the same time it reduces epsilon-cleavage of this fragment, which leads to low production of the APP intracellular domain (AICD). NCBI Gene notes that GSAP selectively increases amyloid-beta production through interaction with both gamma-secretase and its substrate, APP-CTF. The protein is located in the trans-Golgi network, within the Golgi apparatus.

The human GSAP gene encodes a protein of the GSAP family. It was previously named pigeon homolog (Drosophila) and is also known as PION and LOC54103. Because accumulation of neurotoxic amyloid-beta is a major hallmark of Alzheimer disease, and gamma-secretase catalyses its formation, GSAP is studied as a selective modulator of this pathway. The mouse ortholog is Gsap.

Alzheimer disease research

Amyloid-beta accumulation is a major hallmark of Alzheimer disease, and GSAP selectively increases its production.

Gamma-secretase regulation

GSAP interacts with gamma-secretase and its substrate to modulate amyloid-beta generation without altering Notch cleavage.

APP processing studies

GSAP promotes gamma-cleavage of APP-CTF while reducing epsilon-cleavage, lowering AICD production.

Golgi and trafficking biology

GSAP localises to the trans-Golgi network, making it relevant to where APP processing is regulated within the cell.

Background

GSAP frequently asked questions

What does GSAP do?

GSAP regulates gamma-secretase activity and specifically activates production of amyloid-beta 40 and 42. It promotes gamma-cleavage of APP-CTF and reduces epsilon-cleavage, giving low AICD output, while leaving cleavage of other substrates such as Notch unaffected.

What other names does GSAP go by?

GSAP stands for gamma-secretase activating protein. It is also known as PION and LOC54103, and its previous HGNC name was pigeon homolog (Drosophila). UniProt lists the protein as Gamma-secretase-activating protein, a member of the GSAP family.

Is GSAP conserved and linked to disease?

A mouse ortholog, Gsap, is recorded. NCBI Gene links GSAP to Alzheimer disease biology through its selective increase of amyloid-beta production. Check the datasheet of any product for its validated reactivity.

Explore

Related targets

Gamma-secretase components, APP pathway proteins and Alzheimer disease-related targets with products at Assay Genie.

Gene and protein annotations from HGNC, NCBI Gene and UniProt A4D1B5; product specifications from Assay Genie datasheets.

GSAP Product listing